Addiction Corporate social responsibility Opioid Pharmaceutical Trust Business Administration Tobacco
The opioid crisis and tobacco addiction represent two of the most significant public health challenges of modern times, each imposing extensive societal, economic, and healthcare burdens. In the United States, opioid overdoses claim tens of thousands of lives annually, prompting the crisis to be declared a public health emergency in 2017. Similarly, tobacco use remains the leading cause of preventable death, with millions succumbing to tobacco-related diseases each year. These crises underscore the urgent need for effective interventions addressing public health implications and industry accountability. Corporate Social Responsibility (CSR) awareness initiatives have emerged as a potential strategy to rebuild the reputation of the pharmaceutical and tobacco industries, both of which have faced sustained criticism for their roles in perpetuating these crises. This study evaluates the effectiveness of CSR programs in addressing public distrust, particularly in industries with deeply entrenched reputational challenges. It examines how CSR familiarity correlates with trust, explores the influence of distrust and demographic factors, and assesses the extent to which these programs achieve their intended objectives.
Metrics
28 File views/ downloads
18 Record Views
Details
Title
Rebuilding reputation through corporate social responsibility awareness
Creators
Preetty Paul Priyesh
Contributors
David Gefen (Advisor)
Awarding Institution
Drexel University
Degree Awarded
Doctor of Business Administration (D.B.A.)
Publisher
Drexel University; Philadelphia, Pennsylvania
Number of pages
vii, 111 pages
Resource Type
Dissertation
Language
English
Academic Unit
Bennett S. LeBow College of Business; Drexel University
Other Identifier
991022040964804721
Research Home Page
Browse by research and academic units
Learn about the ETD submission process at Drexel
Learn about the Libraries’ research data management services